5-Chloro-3-(2-methylimidazol-1-ylmethyl)-pyridazine → HCID 22240113, 화합물
반응식
[F:1][C:2]([C:5]1[CH:6]=[C:7](B2OC(C)(C)C(C)(C)O2)[CH:8]=[CH:9][CH:10]=1)([F:4])[CH3:3].[Cl:20][C:21]1[CH:22]=[C:23]([CH2:27][N:28]2[CH:32]=[CH:31][N:30]=[C:29]2[CH3:33])[N:24]=[N:25][CH:26]=1>>[ClH:20].[F:4][C:2]([C:5]1[CH:6]=[C:7]([C:21]2[CH:22]=[C:23]([CH2:27][N:28]3[CH:32]=[CH:31][N:30]=[C:29]3[CH3:33])[N:24]=[N:25][CH:26]=2)[CH:8]=[CH:9][CH:10]=1)([F:1])[CH3:3]참가 물질
3
실험 절차
The title compound, MS: m/e=315.4 (M+H+), was prepared from 2-[3-(1,1-difluoro-ethyl)-phenyl]-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane and 5-chloro-3-(2-methyl-imidazol-1-ylmethyl)-pyridazine.
출처 및 근거
- ORD 기록
- ord-67cb9e4aa974486a9e181262e7201e77
- 출처 데이터셋
- uspto-grants-2006_02
- 특허 번호
- US07005432B2
반응 노트
불러오는 중…